The state of New Mexico urged a judge to hold Walgreens Boots Alliance Inc responsible for fueling the opioid crisis in the state.
Dan Alberstone, a lawyer for New Mexico, told Judge Francis Matthew in the 1st Judicial Circuit of New Mexico in Santa Fe, that the opioid crisis existing in New Mexico was a foreseeable consequence of Walgreens' conduct."
Alberstone accused the company of failing to "maintain effective controls" against the diversion of opioids onto the black market, saying it dispensed suspicious prescriptions without adequate due diligence or documentation.
Steven Derringer, the lawyer arguing for Walgreens, insisted that the opioid crisis was caused by excessive prescriptions and smaller, "mom and pop" pharmacies with lax controls. He added that the state had not offered any evidence that Walgreens dispensed any prescriptions without "legitimate medical purpose."
When the non-jury trial began six weeks ago, it also included claims against Walmart Inc and Kroger Co, but those companies settled with the state last month.


Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Estée Lauder Sues Jo Malone Over Trademark Dispute Involving Zara
U.S. Stock Futures Steady as Iran Reviews U.S. Ceasefire Proposal
Federal Reserve Crisis: DOJ Standoff Threatens Powell's Succession and Rate Stability
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco
Trump Administration Settles Lawsuit Barring Federal Agencies from Pressuring Social Media Censorship
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Microsoft Backs Anthropic in Legal Fight Against Pentagon's AI Blacklist
Rio Tinto's Resolution Copper Mine: U.S. Smelting Challenges and Global Operations Update
Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism
California Court Rejects xAI Bid to Block AI Data Transparency Law
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Oil Prices Plunge Over 6% as Middle East Ceasefire Hopes Ease Supply Fears 



